No Data
No Data
Perfect Medical Schedules Board Meeting for Interim Results
Perfect medical (01830.HK) held a board of directors meeting on November 29 to approve and issue the interim performance.
Gelonghui November 15th | perfect medical (01830.HK) announced that the company will hold a board of directors meeting on November 29, 2024 (Friday) to approve and publish the interim performance of the company and its subsidiaries for the six months ending on September 30, 2024, and consider the payment of interim dividends (if any).
Market Participants Recognise Perfect Medical Health Management Limited's (HKG:1830) Earnings
Aesthetic medicine stocks are under pressure, and Sisram Medical (01696) fell by 4.02%. Daiwa expects macro and policy factors to suppress the growth of cosmetic medicine companies in the second half of the year.
Aesthetic medicine concept stocks are under pressure, with Sisram Med (01696) falling 4.02%, Haohai Biotech (06826) falling 2.18%, Perfect Medical (01830) falling 1.92%, and Rui'er Group (06639) falling 1.39%. On the news side, Morgan Stanley's report pointed out that under the sustained anti-corruption factor in the mainland, the market is expected to have weak second-quarter performance of medical technology companies. Investors are concerned about the timing and scale of the upcoming central government's fiscal stimulus plan, which sets expectations for medical technology stocks for the second half of this year and next year. Meanwhile, macro and policy aspects
Perfect Medical Health Management Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
HTSC: Different performance for beauty and medical beauty in Q2. Q3 may be more challenging for new product sales during off-season.
In Q3 24, it is the off-season for the industry, but also an important window period for many brand manufacturers to prepare for the November 11 shopping festival. It is recommended to pay close attention to new product developments.
No Data
No Data